Hofseth Biocare ASA: KEY INFORMATION RELATING TO THE SUBSEQUENT OFFERING

Reference is made to the announcement by Hofseth BioCare ASA on 16 October 2020 concerning the completion of a private placement with total gross proceeds of approximately NOK 200 million and a contemplated subsequent offering (the " Subsequent Offering ").Date on which the terms of the Subsequent Offering was announced:16 October 2020Last day including right:15 October 2020First day excluding right:16 October 2020Record date:19 October 2020EGM date:On or about 11...

Reference is made to the announcement by Hofseth BioCare ASA on 16 October 2020 concerning the completion of a private placement with total gross proceeds of approximately NOK 200 million and a contemplated subsequent offering (the "Subsequent Offering").

Date on which the terms of the Subsequent Offering was announced:	16 October 2020
Last day including right:	15 October 2020
First day excluding right:	16 October 2020
Record date:	19 October 2020
EGM date:	On or about 11 November 2020
Maximum number of new shares:	4,938,271
Subscription price:	NOK 8.10
Shall the rights be listed	No

This information is published in accordance with the requirements of the Continuing Obligations.